Evelo Biosciences, Inc. 4/A SEC Filings

Filed On	Filing
10 May 2023	Form 4/A: Gill Simba, Director Exercised 23,437 Restricted Stock Units
01 Feb 2021	Form 4/A: Zung Jonathan B., Chief Development Officer Granted 300,000 Stock Option (Right to Buy) · Granted 10,000 Restricted Stock Units

Comments